Cumulative Helicobacter pylori eradication rates in Slovenia in the year 2008;Uspešnost zdravljenja okužbe z bakterijo Helicobacter pylori v Sloveniji v letu 2008

Zdravniski Vestnik

Volumn 79, Issue 1, 2010, Pages 19-24

  Tepeš, Bojan ^a   Ojsteršek, Zvezdana ^a  

^a Diagnosti ni Center Roga ka   (Slovenia)

Author keywords

Antimicrobial therapy; Cross sectional study; Eradication rate; Helicobacter pylori; Urea breath test

Indexed keywords

EID: 79951869054     PISSN: 13180347     EISSN: 15810224     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, et al. Current Concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut 2007; 56: 772-81. (Pubitemid 46854190)
2. Tepeš B, Križman I. Priporočila za zdravljenje okužbe s Helicobacterjem pylori v Sloveniji. Zdrav Vestn 1998; 67: 159-62
3. Tepeš B. Helicobacter pylori v novem milenijumu. Gastroenterolog 2004; 8 : Supl. 2: 54-9.
4. Bochenek VJ, Peters S, Fraga PD. Helicobacter pylori pantoprazole eradication (HELPPE) study group. Eradication of Helicobacter pylori by 7-day triple regiments combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies. Helicobacter 2003; 8: 626-42. (Pubitemid 37553437)
5. Tepeš B, Gubina M. Razlogi za neuspeh antimikrobnega zdravljenja okužbe z bakterijo Helicobacter pylori in naše terapevtske možnosti. Zdrav Vestn 2004; 73: 503-6.
6. Tepeš B. Primerjava dveh trotirnih antimikrobnih shem zdravljenja okužbe z bakterijo Helicobacter pylori. Zdrav Vestn 2000; 69: 505-8.
7. Laine L, Hunt R, El Zimaity H. Bismuth-based quadruple therapy using a single capsule of bismuth bisalicilate, metronidazole and tetracycline given with omeprazole versus omeprazole amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomised, multicenter North American trial. Am J Gastroenterol 2003; 98: 562-7. (Pubitemid 36348526)
8. Rokkas T, Sechopoulos P, Robotis I, Margantinis G, Pistiolas D. Cumulative H. pylori eradication rates in clinical practice by adopting first and second line regimens proposed by Maastricht III consensus and a third line empirical regimen. Am J Gastroenterol 2009; 104: 21-5.
9. Vakil N, Megraud F. Eradication therapy for Helicobacter pylori. Gastroenterology 2007; 133: 996-1001.
10. Gubina M, Tepeš B, Gorenšek M, Križman I, Ihan A, Poljak M. Sensitivity of Helicobacter pylori to eight antibiotics . The 5 th International conference of the Macrolides, Azolides, Streptogromines and ketolides. Sevilla; 2000.
11. Ford A, Moayyedi P. How can the current strategies for Helicobacter pylori eradication be improved ? Can J Gastroenterol 2003;17 Supl. B: 36-40.
12. Jafri NS, Hornung CA, Howden CW. Meta - analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. Ann Intern Med 2008; 12: 923-31. (Pubitemid 351860824)
13. Gisbert JP, De la Morena F. Systemic review and meta analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Aliment Pharmacol Ther 2006; 23: 35-44. (Pubitemid 43381164)
14. Eagan B, Marzio L, O'Connor H, O'Morain C. Treatment of Helicobacter pylori infection. Helicobacter 2008; 13 Supl. 1: 35-40.
15. Gubina M, Tepeš B, Vidmar G, Logar J, Wraber B, Poljanec J, Bricelj I, et al. Prevalenca okužbe z bakterijo Helicobacter pylori v Sloveniji v letu 2005. Zdrav Vestn 2006; 75: 169-73.